Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

W. Chung | R. Nussbaum | F. Couch | B. Bonanni | O. Olopade | T. Rebbeck | B. Karlan | J. Benítez | R. Eeles | E. John | A. Spurdle | W. Foulkes | M. Southey | D. Easton | G. Rennert | A. Richardson | M. Greene | K. Offit | A. Antoniou | N. Loman | S. Buys | D. Eccles | G. Chenevix-Trench | H. Nevanlinna | U. Hamann | C. Lázaro | K. Nathanson | T. Pastinen | J. Garber | M. Blok | C. Isaacs | K. Aittomäki | H. Meijers-Heijboer | A. Meindl | R. Schmutzler | I. Andrulis | G. Glendon | A. Mulligan | P. Radice | P. Peterlongo | S. Manoukian | A. Jakubowska | A. Toland | F. Fostira | S. Teo | J. Simard | S. Nord | S. Neuhausen | C. Sutter | A. V. D. van den Ouweland | M. Robson | S. Gayther | J. Kirk | L. Forétova | L. McGuffog | A. Godwin | E. Friedman | N. Tung | E. Imyanitov | P. Ganz | T. Slavin | A. Osorio | P. Hulick | S. Tognazzo | B. Wappenschmidt | Z. Stadler | N. Sevenet | S. Domchek | D. Stoppa-Lyonnet | Sue-Kyung Park | M. Kriege | J. Oosterwijk | P. Ganschow | D. Frost | S. Mazoyer | F. Hogervorst | C. Engel | C. Singer | K. Claes | J. Rantala | B. Arun | U. Jensen | S. Hart | F. Damiola | A. Arason | O. Díez | Austin Miller | E. Hahnen | B. Buecher | A. Gerdes | P. James | M. Daly | A. Bradbury | R. B. van der Luijt | G. Fountzilas | D. Goldgar | M. Thomassen | A. Droit | B. Ejlertsen | J. Lester | M. Teixeira | P. Berthet | M. Tischkowitz | J. Chiquette | M. Terry | B. Peissel | C. Phelan | J. Gronwald | M. Rookus | L. Feliubadaló | F. Lesueur | L. Izatt | E. Oláh | C. Brewer | R. Davidson | P. Soucy | D. Barrowdale | T. V. Hansen | M. Montagna | E. J. van Rensburg | M. Caligo | R. Janavicius | J. Wijnen | J. Adlard | L. Papi | N. Arnold | R. Varon‐Mateeva | Z. Einbeigi | G. Rodriguez | M. Tea | Y. Laitman | I. Pedersen | Y. Ding | Á. Teulé | J. Loud | M. de la Hoya | C. M. Dorfling | L. Tihomirova | C. Kets | K. Kaczmarek | Audrey Lemaçon | J. Azzollini | V. Bonadona | J. Sokolowska | K. Ong | K. Snape | K. van Engelen | Y. Tan | V. Joseph | K. De Leeneer | G. Sukiennicki | A. Liljegren | L. Barjhoux | R. Dolcetti | Y. Hamdi | J. Hays | A. Bane | P. Shah | P. Segura | D. Gareth Evans | M. Mariani | Kristie A. Bobolis | W. Just | I. M. H. Sønderstrup | Goska Leslie | Karoline B. Kuchenbaeker | Maïté Laurent | C. Rappaport-Fuerhauser | L. Foretova | A. Teule | Johanna Sokolowska | Silje Nord | E. Friedman | M. Teixeira | Johanna Rantala | Katarzyna Kaczmarek

[1]  Arnaud Droit,et al.  metagene Profiles Analyses Reveal Regulatory Element’s Factor-Specific Recruitment Patterns , 2016, PLoS Comput. Biol..

[2]  Li Teng,et al.  4DGenome: a comprehensive database of chromatin interactions , 2015, Bioinform..

[3]  Mads Thomassen,et al.  Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. , 2015, JAMA.

[4]  Li Teng,et al.  4DGenome: a comprehensive database of chromatin interactions , 2015, Bioinform..

[5]  B. Stranger,et al.  Expression QTL-based analyses reveal candidate causal genes and loci across five tumor types. , 2014, Human molecular genetics.

[6]  P. Deloukas,et al.  Allelic expression mapping across cellular lineages to establish impact of non-coding SNPs , 2014, Molecular systems biology.

[7]  T. Rebbeck,et al.  Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[8]  K. Tan,et al.  Global view of enhancer–promoter interactome in human cells , 2014, Proceedings of the National Academy of Sciences.

[9]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[10]  Diana Eccles,et al.  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. , 2013, Journal of the National Cancer Institute.

[11]  W. Chung,et al.  Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.

[12]  D. Altshuler,et al.  Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk , 2013, PLoS genetics.

[13]  P. Deloukas,et al.  Powerful Identification of Cis-regulatory SNPs in Human Primary Monocytes Using Allele-Specific Gene Expression , 2012, PloS one.

[14]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[15]  A. Antoniou,et al.  Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers , 2012, Journal of internal medicine.

[16]  D. Easton,et al.  Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations , 2012, Genetic epidemiology.

[17]  Mads Thomassen,et al.  Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 , 2011, Breast Cancer Research.

[18]  F. Couch,et al.  Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. , 2011, Cancer research.

[19]  B. Bain,et al.  Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. , 2011, Blood.

[20]  C. Carlson,et al.  Principles for the post-GWAS functional characterization of cancer risk loci , 2011, Nature Genetics.

[21]  Scott T. Weiss,et al.  Global Analysis of the Impact of Environmental Perturbation on cis-Regulation of Gene Expression , 2011, PLoS genetics.

[22]  Mathieu Blanchette,et al.  Global patterns of cis variation in human cells revealed by high-density allelic expression analysis , 2009, Nature Genetics.

[23]  Alun Thomas,et al.  Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. , 2009, American journal of human genetics.

[24]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[25]  R. Milne.  Variants in the ATM gene and breast cancer susceptibility , 2009, Genome Medicine.

[26]  C. Begg,et al.  Variation of breast cancer risk among BRCA1/2 carriers. , 2008, JAMA.

[27]  F. Couch,et al.  RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. , 2007, American journal of human genetics.

[28]  Yurii S. Aulchenko,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .

[29]  Georgia Chenevix-Trench,et al.  An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) , 2007, Breast Cancer Research.

[30]  Giovanni Parmigiani,et al.  Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. King,et al.  Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[33]  B. Kennedy,et al.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.

[34]  B. Dynlacht,et al.  Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. , 1998, Genes & development.

[35]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[36]  T. Hashimoto,et al.  Molecular cloning and sequence of the complementary DNA encoding human mitochondrial acetoacetyl-coenzyme A thiolase and study of the variant enzymes in cultured fibroblasts from patients with 3-ketothiolase deficiency. , 1990, The Journal of clinical investigation.